Tributyrin

What Is Tributyrin?

Tributyrin is a triglyceride — a glycerol backbone esterified with three molecules of butyric acid. Chemically it is the simplest way to package butyrate into a stable, fat-soluble form that behaves like a dietary fat rather than a salt.

That distinction is the entire point. Butyrate is one of the most studied short-chain fatty acids (SCFAs) in human health: it is the primary fuel for colonocytes, a histone deacetylase (HDAC) inhibitor, and a regulator of gut barrier integrity and immune tone. The problem has never been butyrate's biology — it has always been getting it to the colon intact.

The Delivery Problem Tributyrin Solves

Take oral sodium butyrate and most of it is absorbed in the upper GI tract or neutralised by stomach acid long before it reaches the distal colon — precisely the region where the colonocytes that depend on butyrate live, and where dysbiosis and barrier breakdown are most common. Enteric coating helps, but delivery remains inconsistent.

Tributyrin behaves differently. Because it is a triglyceride, it is handled like dietary fat:

• It survives gastric passage without dissociating
• Pancreatic and intestinal lipases cleave it in the small and large intestine
• Cleavage is meal-stimulated, so taking it with food times butyrate release to digestion
• Free butyrate is liberated progressively along the gut, including the distal colon

The result is a slower, more distal, more physiological butyrate exposure than a bolus of sodium salt can achieve. Animal models consistently show higher and more sustained colonic butyrate concentrations from tributyrin than from equimolar sodium butyrate.

What Butyrate Actually Does

Once released, butyrate drives several mechanisms relevant to gut and metabolic health:

• Colonocyte fuel — colonocytes derive 60-70% of their energy from butyrate via beta-oxidation. Adequate butyrate keeps the epithelial barrier metabolically healthy.
• HDAC inhibition — butyrate is a class I/IIa HDAC inhibitor, shifting gene expression toward anti-inflammatory and tight-junction-supporting patterns.
• Tight junction support — upregulation of occludin and claudin proteins reduces intestinal permeability ("leaky gut").
• Treg induction — butyrate promotes regulatory T-cell differentiation in the colon, dampening inappropriate immune activation.
• Gut-brain and metabolic signalling — butyrate engages FFAR2/FFAR3 receptors, influencing GLP-1 secretion, satiety, and systemic inflammation.

Evidence Status — Be Honest

This is where calibration matters. The molecular biology of butyrate is grade-A; the human clinical evidence for tributyrin specifically as a supplement is still early:

• The bulk of direct tributyrin data is preclinical (rodent colitis, barrier, and metabolic models), where it reliably outperforms sodium butyrate on colonic delivery.
• Human butyrate data largely comes from sodium butyrate and from fibre-driven endogenous butyrate production, not from oral tributyrin RCTs.
• Tributyrin's case rests on a strong mechanistic and pharmacokinetic argument — better delivery of a molecule we already know is beneficial — rather than on large outcome trials.

That earns it an evidence grade of C: mechanistically compelling, delivery-superior, but under-tested in humans as a standalone product. Treat confident "tributyrin cures X" marketing with suspicion.

Tributyrin vs Sodium Butyrate

For a deeper treatment of the trade-off, see the companion article Tributyrin vs Sodium Butyrate: Why The Form Matters.

Dosing

• Typical: 300-600 mg tributyrin with meals, once or twice daily
• Higher protocols: up to ~1,200 mg/day split across meals
• Timing: always with food — lipase activity, and therefore butyrate release, is meal-stimulated
• Duration: barrier and microbiome effects accrue over 8-12 weeks; this is not an acute intervention

Start low. While GI tolerance is good, introducing any SCFA prodrug too aggressively can cause loose stools or cramping during the first week.

Who Might Consider It

• Those targeting distal colonic barrier support where sodium butyrate delivery falls short
• Microbiome-optimisation stacks alongside Akkermansia and fibre
• People who cannot tolerate the strong odour and reflux of sodium butyrate
• Post-antibiotic dysbiosis recovery as an adjunct (not a replacement for addressing diet and fibre)

Quality Considerations

• Look for products specifying tributyrin content (not just "butyrate complex")
• Some formulations blend tributyrin with calcium/magnesium butyrate — fine, but read the label for the actual tributyrin dose
• Softgel or oil-matrix formats suit the lipid nature of the molecule
• As with all SCFA products, third-party testing is sparse — favour established brands

Related Research

• Tributyrin vs Sodium Butyrate: Why The Form Matters
• Akkermansia muciniphila: The Next-Generation Probiotic for Metabolic Health
• The Gut-Longevity Connection: Microbiome Optimisation Stack for Healthspan (2026)